Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Flick, H; Arns, BM; Bolitschek, J; Bucher, B; Cima, K; Gingrich, E; Handzhiev, S; Hochmair, M; Horak, F; Idzko, M; Jaksch, P; Kovacs, G; Kropfmüller, R; Lamprecht, B; Löffler-Ragg, J; Meilinger, M; Olschewski, H; Pfleger, A; Puchner, B; Puelacher, C; Prior, C; Rodriguez, P; Salzer, H; Schenk, P; Schindler, O; Stelzmüller, I; Strenger, V; Täubl, H; Urban, M; Wagner, M; Wimberger, F; Zacharasiewicz, A; Zwick, RH; Eber, E.
Management of patients with SARS-CoV-2 infections and of patients with chronic lung diseases during the COVID-19 pandemic (as of 9 May 2020) : Statement of the Austrian Society of Pneumology (ASP).
Wien Klin Wochenschr. 2020; [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Eber Ernst
Flick Holger
Kovacs Gabor
Meilinger Michael
Olschewski Horst
Pfleger Andreas
Salzer Helmut J. F.
Strenger Volker
Wagner Marlies
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Number of Figures: 6
| | | | | |
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic is currently a challenge worldwide. In Austria, a crisis within the healthcare system has so far been prevented. The treatment of patients with community-acquired pneumonia (CAP), including SARS-CoV‑2 infections, should continue to be based on evidence-based CAP guidelines during the pandemic; however, COVID-19 specific adjustments are useful. The treatment of patients with chronic lung diseases has to be adapted during the pandemic but must still be guaranteed.

Find related publications in this database (Keywords)
SARS-CoV-2
COVID-19
Community acquired pneumonia
ARDS
Chronic lung disease
© Med Uni Graz Impressum